Literature DB >> 9643710

150 years of pharmacovigilance.

P Routledge1.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9643710     DOI： 10.1016/S0140-6736(98)03148-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

Review 1.  Adverse drug reactions: back to the future.

Authors:  Munir Pirmohamed; B Kevin Park
Journal:  Br J Clin Pharmacol       Date:  2003-05       Impact factor: 4.335

2.  Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital.

Authors:  A Vallano; G Cereza; C Pedròs; A Agustí; I Danés; C Aguilera; J M Arnau
Journal:  Br J Clin Pharmacol       Date:  2005-12       Impact factor: 4.335

3.  Postmarketing adverse drug reactions: A duty to report?

Authors:  Eran Klein; Dennis Bourdette
Journal:  Neurol Clin Pract       Date:  2013-08

4.  A Review of Pharmacovigilance.

Authors:  J E Campbell; M Gossell-Williams; M G Lee
Journal:  West Indian Med J       Date:  2015-03-05       Impact factor: 0.171

Review 5.  [Pharmacovigilance in Germany : It is about time].

Authors:  A Douros; C Schaefer; R Kreutz; E Garbe
Journal:  Internist (Berl)       Date:  2016-06       Impact factor: 0.743

Review 6.  Active pharmacovigilance in China: recent development and future perspectives.

Authors:  Xinling Li; Haona Li; Jianxiong Deng; Feng Zhu; Ying Liu; Wenge Chen; Zhihua Yue; Xuequn Ren; Jielai Xia
Journal:  Eur J Clin Pharmacol       Date:  2018-04-10       Impact factor: 2.953

7.  The incidence of adverse events and risk factors for upper gastrointestinal disorders associated with meloxicam use amongst 19,087 patients in general practice in England: cohort study.

Authors:  R M Martin; P Biswas; R D Mann
Journal:  Br J Clin Pharmacol       Date:  2000-07       Impact factor: 4.335

Review 8.  Consumer adverse drug reaction reporting: a new step in pharmacovigilance?

Authors:  Kees van Grootheest; Linda de Graaf; Lolkje T W de Jong-van den Berg
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

9.  A pilot randomised controlled trial to assess the utility of an e-learning package that trains users in adverse drug reaction causality.

Authors:  Elizabeth J Conroy; Jamie J Kirkham; Jennifer R Bellis; Matthew Peak; Rosalind L Smyth; Paula R Williamson; Munir Pirmohamed
Journal:  Int J Pharm Pract       Date:  2015-05-29

10.  The knowledge, attitude and behaviours of nurses about pharmacovigilance, adverse drug reaction and adverse event reporting in a state hospital.

Authors:  Fisun Vural; Seval Ciftci; Birol Vural
Journal:  North Clin Istanb       Date:  2015-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.